Skip to main navigation menu Skip to main content Skip to site footer
Submitted July 22, 2022
Published 2022-07-22

Artículos

Vol. 1 No. 2 (2022): REDEPSIC

VARIABLES ASOCIADAS A LA CALIDAD DE VIDA EN PACIENTES ADULTOS EN TRATAMIENTO DE HEMODIÁLISIS. ECUADOR


Cover image

Citación:
DOI: ND

Published: 2022-07-22

How to Cite

Serrano Patten, A. C., & Astudillo León, J. C. (2022). VARIABLES ASOCIADAS A LA CALIDAD DE VIDA EN PACIENTES ADULTOS EN TRATAMIENTO DE HEMODIÁLISIS. ECUADOR. REDEPSIC, 1(2), 8–26. Retrieved from https://revistas.up.ac.pa/index.php/redepsic/article/view/3092

Abstract

The 21st century has been characterized by demographic aging and an increase in chronic non-communicable diseases that annually cause the death of 15 million people worldwide. One of these is chronic kidney disease (CKD), with a prevalence in Latin America of 650 patients per million inhabitants, whose quality of life is affected by the clinical picture and treatment. The present study was aimed at analyzing health-related quality of life (HRQOL) and its association with sociodemographic, clinical and psychological variables, evaluated in patients with renal failure undergoing hemodialysis treatment. This is a quantitative, correlational, cross-sectional study. We worked with 23 adult patients from the province of Morona Santiago, Ecuador.  Information was obtained through a general data sheet, the Kidney Disease Quality of Life (KDQOL-36), the Disease Identity Questionnaire (CIE-E) and the Therapeutic Adherence Scale (EAT). As a result, the patients have a perception of deterioration of HRQOL, the therapeutic adherence of 69.5% of the participants is moderate and the regularity with which the disease has been integrated into the personal identity of these patients is maladaptive. There is negative correlation between HRQOL and the variables: age ? (rho) = -.288**, time of diagnosis with ? (rho) = -.114* and the absorption dimension of illness identity (IE) ? (rho) = -.62*. There are statistically significant positive correlations with therapeutic adherence and the IE acceptance dimension.

Downloads

Download data is not yet available.